By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the relationship between insomnia and substance use disorders,
2) identify non-pharmacologic approaches to treating insomnia,
3) identify risks and benefits of pharmacologic options for insomnia for patients with substance use disorders, and
4) apply harm reduction and shared decision-making when supporting sleep pharmacotherapy in the context of substance use disorder treatment
Insomnia and Substance Use Disorders: Clinical Considerations for Primary Care
Past Session
Thursday, June 25 2026, 12:00pm to 1:00pm PT
Presented by Megan Ireland